24 studies found for:    NIAID | Open Studies | Exclude Unknown | tuberculosis
Show Display Options
Rank Status Study
1 Recruiting Multi-Drug Resistant Tuberculosis in Korea
Conditions: Tuberculosis;   Pulmonary Tuberculosis
Intervention:
2 Recruiting Determining Risk in Latent Tuberculosis
Condition: Latent Tuberculosis
Intervention:
3 Not yet recruiting Effect of Filarial Infection on Immune Responses in Latent Tuberculosis
Conditions: Tuberculosis;   Filariasis
Intervention:
4 Recruiting Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis
Condition: Tuberculosis
Interventions: Drug: RIF;   Drug: INH;   Drug: PZA;   Drug: KM;   Drug: MXF
5 Recruiting Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary Tuberculosis
Conditions: Tuberculosis;   Urea Breath Test
Intervention:
6 Recruiting Training Protocol on the Natural History of Tuberculosis
Condition: Tuberculosis
Intervention:
7 Recruiting Gene Expression in HIV and Tuberculosis Co-infection
Conditions: Tuberculosis;   HIV;   IRIS
Intervention:
8 Recruiting Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection
Conditions: Tuberculosis;   HIV Infections
Interventions: Drug: Rifapentine (RPT);   Drug: Isoniazid (INH);   Dietary Supplement: Pyridoxine (Vitamin B6)
9 Recruiting Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin
Condition: Tuberculosis
Interventions: Drug: PA-824;   Drug: Efavirenz (EFV);   Drug: Lopinavir/Ritonavir (LPV/r);   Drug: Rifampin (RIF)
10 Recruiting Phase 2a EBA Trial of AZD5847
Condition: Mycobacterium Tuberculosis
Interventions: Drug: Rifafour;   Drug: AZD5847
11 Recruiting Efavirenz (EFV) in HIV-Infected and HIV/Tuberculosis (TB) Coinfected Children
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Efavirenz (EFV);   Drug: Rifampin-containing anti-TB therapy
12 Not yet recruiting Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Isoniazid (INH);   Drug: Placebo for isoniazid (INH)
13 Not yet recruiting Challenge Model for Assessment of Human TB Immunity
Condition: Mycobacterium Tuberculosis
Intervention: Biological: Tice® BCG
14 Not yet recruiting SQ109 Thorough QT Study
Condition: Tuberculosis
Interventions: Other: SQ109 Placebo;   Drug: Moxifloxacin;   Drug: SQ109
15 Not yet recruiting Evaluating the Safety, Tolerance, Drug Interactions, and Effective Dosing of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in ART-Naive Children Infected With HIV and TB
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: Raltegravir
16 Recruiting Latency in Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Intervention: Drug: Moxifloxacin, Isoniazid, Rifampicin Pyrazinamide, Ethambutol
17 Recruiting Rapid Diagnosis of Pulmonary Tuberculosis
Condition: Tuberculosis
Interventions: Drug: Salbutamol;   Drug: Sodium chloride 5%
18 Recruiting Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV
Conditions: HIV Infection;   Tuberculosis
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Raltegravir;   Drug: Isoniazid;   Drug: Pyridoxine;   Drug: Pyrazinamide;   Drug: Ethambutol;   Drug: Rifabutin;   Drug: Rifampin
19 Not yet recruiting Early Bactericidal Activity (EBA) Study of Tuberculosis Regimens With and Without INH and Moxifloxacin
Condition: Tuberculosis
Interventions: Drug: Rifampicin;   Drug: Isoniazid;   Drug: Pyrazinamide;   Drug: Ethambutol;   Drug: Moxifloxacin
20 Recruiting Interferon-Gamma Release Assays in Tuberculosis (TB) - HIV Co-infected Children
Conditions: Tuberculosis;   HIV
Interventions: Procedure: Interferon-Gamma Release Assay;   Drug: RT-23

Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results
Indicates status has not been verified in more than two years